Canadian investment regulator resumes trading oversight to ensure market integrity
Investor Watchlist highlights key small-cap stocks facing growth challenges, with some firms showing improved profitability or cash generation, while others face risks like weak revenue, high costs, and cash burn.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Canadian investment regulator resumes trading oversight to ensure market integrity
Investor Watchlist highlights key small-cap stocks facing growth challenges, with some firms showing improved profitability or cash generation, while others face risks like weak revenue, high costs, and cash burn.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.